Position in GSK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$690,056
+$3,438 QoQ
Shares Held
13,164
+5.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#413
of 1,033 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADVISORTRUST PARTNERS, LLC holds $21,975,965 across 9 Drug Manufacturers - General names. GSK ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,546 | $6,487,917 | |
| 2 | MRK |
Merck & Co., Inc.
|
42,883 | $5,510,465 | |
| 3 | AZN |
Astrazeneca PLC
|
28,284 | $5,363,212 | |
| 4 | LLY |
ELI LILLY & Co
|
1,473 | $1,766,760 | |
| 5 | ABBV |
AbbVie Inc.
|
4,298 | $1,081,548 | |
| 6 | GSK |
GSK plc
This page
|
13,164 | $690,056 | |
| 7 | SNY |
Sanofi
|
10,694 | $456,206 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,845 | $359,437 |
All Filings in GSK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $690,056 | 13,164 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $686,618 | 12,441 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $725,742 | 14,799 | Shares | Sole | 2026-03-10 | |
| No filing history on record for this holder in this stock. | ||||||